Related Experiment Videos
[A case-control study of acute leukemia during the 1st year of life]
Insights
Infantile leukemias (IL) present unique biological markers like higher white blood cell counts and IgM levels in acute lymphoblastic leukemia (ALL). These differences may impact treatment outcomes for young children with leukemia.
Area of Science:
- Pediatric Oncology
- Hematology
- Cancer Biology
Context:
- Infantile leukemias (IL), diagnosed within the first year of life, represent a rare subset (<5%) of childhood leukemias.
- Understanding the distinct biological characteristics of IL is crucial for improving diagnosis and treatment strategies.
- This study compares IL cases with age-matched controls to identify key differences.
Purpose:
- To analyze the clinical and biological features of infantile leukemias (IL).
- To compare IL with older children diagnosed with similar leukemia types (acute lymphoblastic leukemia [ALL] and acute non-lymphoblastic leukemia [ANLL]).
- To investigate potential differences in survival rates based on specific biological markers.
Summary:
- Analysis of 24 IL cases revealed significant differences compared to controls: higher initial white blood cell (WBC) count and IgM levels in ALL, and a higher prevalence of M4/M5 morphology in ANLL.
- Infantile ALL cases with an initial WBC count >50,000/mm³ showed significantly shorter survival compared to a control group (age 3-6 years).
- These findings highlight distinct biological profiles in IL that may influence disease progression and treatment response.
Impact:
- Identifies specific biological markers (WBC, IgM, morphology) that differentiate infantile leukemias from those in older children.
- Suggests that certain biological characteristics in infantile ALL may be associated with poorer prognosis, warranting further investigation.
- Provides valuable insights for refining diagnostic criteria and developing targeted therapeutic approaches for the youngest leukemia patients.
Abstract:
Infantile leukemias (IL) with onset of the disease in the first year of life account for less than 5% of childhood leukemias. Twenty-four IL cases (age at diagnosis [AD] less than 1 year), treated in a single institution over a 15 year period were analyzed. IL cases were paired with elder leukemic children, matched by type of leukemia (ALL and ANLL), sex, year of diagnosis, and regional residence. For ALL 2 control groups (CG) were chosen: AD 3-6 years (CG1), corresponding to ALL incidence peak in Italy, and AD 6-14 years (CG2); for ANLL (not having age specific incidence peak): AD greater than 3 years. In ALL the main biological differences between IL and CGs are represented by initial WBC count and IgM at onset, significantly higher in IL cases (p less than 0.01 and 0.05, respectively). In ANLL a significant excess of M4/M5 morphology was found among IL (p less than 0.01). Moreover, a significantly shorter survival was found in infantile ALLs vs. CG1, in the stratum with WBC count at onset greater than 50,000/mm3 (p less than 0.05).